Table 2.
Assessment of study quality.
| Quality indicators from Newcastle-Ottawa Scale | Kumor et al. [24] | Gonullu et al. [26] | Nakajima et al. [23] | Danese et al. [27] | Joshi et al. [18] | Lu et al. [28] | Tulubas et al. [21] | Wägsäter et al. [29] | Kosova et al. [25] | Hillenbrand et al. [32] |
|---|---|---|---|---|---|---|---|---|---|---|
| Independent validation of case definition | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | No | No |
| Consecutive or obviously representative series of cases | No | No | Yes | No | No | No | Yes | Yes | Yes | No |
| Community controls | No | No | No | No | No | No | No | Yes | No | No |
| Controls have negative colonoscopy | Yes | Yes | Yes | Yes | No | No | Yes | No | No | No |
| Study controls for age/gender | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Study controls for BMI | Yes | Yes | Yes | Yes | No | No | Yes | No | No | No |
| Secure record of resistin levels with blinded interview | No | No | No | No | No | No | No | No | No | No |
| The same method of resistin measurement for cases and controls | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| The same nonresponse rate for cases and controls | No | No | No | No | No | No | No | No | No | No |
| Score | 5 | 5 | 6 | 5 | 3 | 2 | 6 | 6 | 2 | 2 |